Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/11/2008US20080306147 Illudin Analogs Useful as Anticancer Agents
12/11/2008US20080306146 Dosing Regimens for Cox-2 Inhibitor
12/11/2008US20080306145 Preparation Of Ginkgolide And F-Seco-Ginkgolide Lactols
12/11/2008US20080306144 Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors
12/11/2008US20080306143 Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders
12/11/2008US20080306142 Isolation, purification and synthesis of procyanidin B2 and uses thereof
12/11/2008US20080306141 Method of Extraction of Catechin Type-A Proanthocyanidins
12/11/2008US20080306140 Isoflavonoid Dimers
12/11/2008US20080306139 isolated from a fermentation broth of eubacterium Streptomyces sp. cultures; effective in the treatment of bacterial infections
12/11/2008US20080306137 Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008US20080306135 Process for the Preparation of Crystalline Perindopril
12/11/2008US20080306134 Thalidomide analogs for treating vascular abnormalities
12/11/2008US20080306133 Intranasal administration of asenapine and pharmaceutical compositions therefor
12/11/2008US20080306132 Novel oral compositions of carporen
12/11/2008US20080306131 Progesterone receptor modulator and uses thereof
12/11/2008US20080306130 Inhibitors of ubiquitin E1
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306128 new forms of 2-butyl-1-[2'-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]spiro[2-imidazoline-4.1'-cyclopentane]-5-one; antagonist of angiotensin-II receptors
12/11/2008US20080306127 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
12/11/2008US20080306126 Peroxisome proliferator activated receptor treatment of hyperhomocysteinemia and its complications
12/11/2008US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides
12/11/2008US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
12/11/2008US20080306123 Novel compounds
12/11/2008US20080306122 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; depression or a mood disorder ; modulation of use-dependent voltage-gated sodium channels
12/11/2008US20080306121 Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds
12/11/2008US20080306120 Azaindole inhibitors of aurora kinases
12/11/2008US20080306118 Process for the crystallization of (R) - or (S) - Lansoprazole
12/11/2008US20080306117 Ep4 receptor antagonists
12/11/2008US20080306116 Aryloxazole, aryloxadiazole and benzimidazole derivatives
12/11/2008US20080306115 Midazole-4-Carboxamide Derivatives For Use As Cb1 Modulators
12/11/2008US20080306114 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders
12/11/2008US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione
12/11/2008US20080306112 Benzimidazolones Which Have Activity at M1 Receptor
12/11/2008US20080306111 Tricyclic delta- opioid modulators
12/11/2008US20080306110 Alkylnitrile Quinolines as Nk-3 Receptor Ligands
12/11/2008US20080306109 Indolizine Derivatives as Ligands of the Crth2 Receptor
12/11/2008US20080306108 Substituted Pyridoxines As Anti-Platelet Agents
12/11/2008US20080306107 Compounds
12/11/2008US20080306106 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2008US20080306105 Deuterium-enriched moxifloxacin
12/11/2008US20080306104 Tamper-resistant oral opioid agonist formulations
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306102 Novel spirooxyindole compounds and drugs containing same
12/11/2008US20080306100 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
12/11/2008US20080306099 Compositions and methods for inhibition of the jak pathway
12/11/2008US20080306098 Pharmacokinetics of protease inhibitors and other drugs
12/11/2008US20080306097 Cancer Treatment Method
12/11/2008US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
12/11/2008US20080306094 Combination of Azd2171 and Pemetrexed
12/11/2008US20080306093 Modulation of chemosensory receptors and ligands associated therewith
12/11/2008US20080306092 Pyrazolo [1,5-Alpha] Pyrimidinyl Derivatives Useful as Corticotropin-Releasing Factor (Crf) Receptor Antagonists
12/11/2008US20080306091 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
12/11/2008US20080306090 Thiourea derivatives
12/11/2008US20080306089 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008US20080306088 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306086 for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD); 2-{4-[(2S,4S)-1-benzyl-4-(2,4-difluoro-benzylamino)-pyrrolidine-2-carbonyl]-piperazin-1-yl}-benzonitrile
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306084 Substituted Amide Compounds
12/11/2008US20080306083 Biaryl Compounds Useful as Agonists of the Gpr38 Receptor
12/11/2008US20080306082 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases
12/11/2008US20080306081 Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists
12/11/2008US20080306080 Neutrophilia inhibitor
12/11/2008US20080306079 External preparation for allergic diseases
12/11/2008US20080306078 3,9-Diazabicyclo [3.3.1] Nonane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
12/11/2008US20080306077 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842
12/11/2008US20080306076 Modulation of chemosensory receptors and ligands associated therewith
12/11/2008US20080306075 Pharmaceutical Compositions For Transdermal Delivery
12/11/2008US20080306074 Compositions Comprising Addl Receptors, Related Compositions, and Related Methods
12/11/2008US20080306073 Antitumor Effect Potentiator, Antitumor Preparation, and Method for Treating Cancer
12/11/2008US20080306072 Organic Compounds
12/11/2008US20080306071 Substituted piperidine compounds and methods of their use
12/11/2008US20080306070 Combination Therapy Comprising Substituted Oxazolidinones for the Prevention and Treatment of Cerebral Circulatory Disorders
12/11/2008US20080306069 Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S
12/11/2008US20080306068 Suppression cytokines, tumor necrosis factor
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/11/2008US20080306066 Non-imidazole heterocyclic compounds
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306064 Benzimidazole Derivatives
12/11/2008US20080306063 Phenylamino isothiazole carboxamidines as mek inhibitors
12/11/2008US20080306062 Modulators of atp-binding cassette transporters
12/11/2008US20080306061 Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306059 Pyrimido [4,5-B] -Oxazines For Use as Dgat Inhibitors
12/11/2008US20080306058 Combinations Comprising a Vegf Receptor Inhibitor
12/11/2008US20080306057 P13K Inhibitors for the Treatment of Endometriosis
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306055 Heterocyclic Mchr1 Antagonists And Their Use In Therapy
12/11/2008US20080306054 Pharmaceutical Compounds
12/11/2008US20080306053 Modulation of chemosensory receptors and ligands associated therewith
12/11/2008US20080306052 e.g.1-{3-[5-(4-chlorophenyl)-2-oxo-6H-1,3,4-thiadiazin-3-ylmethyl]phenyl}-3-(1-methylpyrrolidin-3-ylmethyl)urea; inhibitors of tyrosine kinases, in particular Met kinase; antitumor, antiinflammatory agent
12/11/2008US20080306051 HIV Integrase Inhibitors
12/11/2008US20080306050 Aminodiazepines as Toll-Like Receptor Modulators
12/11/2008US20080306049 Therapeutic pyrazoloquinoline derivatives
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080306047 Use of Aza-Phenylalanine Compounds For Treating Cardiac Arrhythmia
12/11/2008US20080306046 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative
12/11/2008US20080306045 1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors
12/11/2008US20080306044 Spirobenzoazepanes as vasopressin antagonists